Skip to main content

Align Technology Q3 FY2026 results

  • ALGN · Nasdaq
  • Medical devices
  • Health Care Supplies
  • S&P 500
$168.32+0.81%Close 13 Nov 2026 · Market value $11.85B

Align Technology reported revenue of $1.01 billion, up 1.9% from a year earlier, net income of $135 million and diluted earnings per share of $1.90 against $0.78 for the third quarter of fiscal 2026 (the three months to 30 Sep 2026).

From its quarterly report, the results first announced on 28 Oct 2026. Compiled and checked by AapWire.

Q3 FY2026 against Q3 FY2025

Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.

Align Technology Q3 FY2026 results against the year-ago quarter
MeasureQ3 FY2026Q3 FY2025Change
Revenue$1.01B$995.7M+1.9%
Gross profit$697.5M$639.2M+9.1%
Gross margin68.7%64.2%+4.5 pts
Operating income$169.2M$96.30M+75.7%
Operating margin16.7%9.7%+7.0 pts
Net income$135.0M$56.75M+138%
Diluted EPS$1.90$0.78+144%
Operating cash flow$182.9M$188.7M−3.1%
Capital expenditure$45.03M$19.76M+128%
Free cash flow$137.9M$169.0M−18.4%

Operating KPIs for the quarter

Align Technology operating KPIs, Q3 FY2026
KPIQ3 FY2026Change on a year
Clear aligner case volume690.6Kup 6.6%
Remaining performance obligations$1.3Bdown 9.6%
Clear Aligner revenue$839.3Mup 4.2%
Systems and Services revenue$175.5Mdown 7.6%

Earlier quarters

Align Technology results, last eight filed quarters
QuarterPeriod endRevenueChange on a yearDiluted EPS
Q3 FY202630 Sep 2026$1.01B+1.9%$1.90
Q2 FY202630 Jun 2026$1.06B+4.3%$1.51
Q1 FY202631 Mar 2026$1.04B+6.2%$1.57
Q4 FY202531 Dec 2025$1.05B+5.3%$1.89
Q3 FY202530 Sep 2025$995.7M+1.8%$0.78
Q2 FY202530 Jun 2025$1.01B−1.6%$1.72
Q1 FY202531 Mar 2025$979.3M−1.8%$1.27
Q4 FY202431 Dec 2024$995.2M+4.0%$1.39

More on Align Technology: financial statements · revenue · earnings per share

ALGN's results, as they are filed.

Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.